Glycogen synthase kinase-3β (GSK-3β) is a significant tau kinase involved in the abnormal hyperphosphorylation of tau protein during AD and a critical effector of phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (Akt) cellular signaling [92]. The gene discussed is MAPT; the disease is Alzheimer disease.